Please note that masks are still required in all Blue Ridge Cancer Care offices regardless of vaccination status.
Learn more about this and other current Covid-19 policies.

Research Institute

Phase 1a/1b Study of LY3484356 in Metastatic Breast Cancer Patient

A Phase 1a/1b Study of LY3484356 Administered as Monotherapy and in Combination with Anticancer Therapies for Patients with ER+ Locally Advanced or Metastatic Breast Cancer and Other Select Non-Breast Cancers

Disease Types: Breast

Available at: AlleghanyBlacksburgRoanokeSalemWytheville

A Phase 1a/1b Study of LY3484356 Administered as Monotherapy and in Combination with Anticancer Therapies for Patients with ER+ Locally Advanced or Metastatic Breast Cancer and Other Select Non-Breast Cancers

For more information:

https://clinicaltrials.gov/ct2/show/NCT04188548?term=A+Phase+1a%2F1b+Study+of+LY3484356+Administered+as+Monotherapy+and+in+Combination+with+Anticancer+Therapies+for+Patients+with+ER%2B+Locally+Advanced+or+Metastatic+Breast+Cancer+and+Other+Select+Non-Breast+Cancers&draw=2&rank=1